Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-10-9
|
pubmed:abstractText |
Production of cGMP is impaired in endotoxin-induced acute lung injury. This results in dysfunction of endothelium-dependent and -independent cGMP-mediated pulmonary vasorelaxation and, therefore, pulmonary hypertension. We hypothesized that cyclic nucleotide phosphodiesterase (PDE) inhibition would attenuate endotoxin-induced impairment to cGMP-mediated mechanisms of pulmonary vasorelaxation. The purpose was to examine the effect of stimulating cGMP production with concurrent inhibition of cGMP catabolism by PDE inhibition following endotoxin-induced acute lung injury. Isolated pulmonary arterial rings from rats (n = 5) were studied 6 hrs after endotoxin (20 mg/kg ip) or saline. In a third group (n = 5), PDE inhibition was accomplished with in vitro 3-isobutyl-1-methylxanthine (IBMX, 1 microM for 30 min). Cyclic GMP-mediated relaxation was interrogated by stimulating (1) endothelium-dependent mechanisms with the receptor-dependent agonist acetylcholine and the receptor-independent agonist A23187, a calcium ionophore, and an (2) endothelium-independent mechanism with sodium nitroprusside. PDE inhibition attenuated endotoxin-induced vasomotor dysfunction. A two-pronged approach-stimulating cGMP production and preventing cGMP catabolism with PDE inhibition-may offer a therapeutically accessible mechanism to overcome vasomotor dysfunction in acute lung injury.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-3-isobutylxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/Calcimycin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP,
http://linkedlifedata.com/resource/pubmed/chemical/Endotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-4804
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1997 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9299282-1-Methyl-3-isobutylxanthine,
pubmed-meshheading:9299282-Animals,
pubmed-meshheading:9299282-Calcimycin,
pubmed-meshheading:9299282-Cyclic GMP,
pubmed-meshheading:9299282-Endothelium, Vascular,
pubmed-meshheading:9299282-Endotoxins,
pubmed-meshheading:9299282-Male,
pubmed-meshheading:9299282-Muscle, Smooth, Vascular,
pubmed-meshheading:9299282-Nitroprusside,
pubmed-meshheading:9299282-Phosphodiesterase Inhibitors,
pubmed-meshheading:9299282-Pulmonary Artery,
pubmed-meshheading:9299282-Rats,
pubmed-meshheading:9299282-Rats, Sprague-Dawley,
pubmed-meshheading:9299282-Respiratory Distress Syndrome, Adult,
pubmed-meshheading:9299282-Vasodilation
|
pubmed:year |
1997
|
pubmed:articleTitle |
Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
|
pubmed:affiliation |
Department of Surgery, University of Colorado, Denver, Colorado, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|